MedPath

Evaluation of the efficacy of dietary carbohydrate restriction intervention in patients with type 2 diabetes.

Not Applicable
Completed
Conditions
Type 2 diabetes
Registration Number
JPRN-UMIN000022910
Lead Sponsor
Kitasato University Kitasato Institute Hospital
Brief Summary

Over 36 months, the mLCD intervention showed sustained effectiveness (without safety concerns) in improving HbA1c, lipid profile, and liver enzymes in Japanese patients with type 2 diabetes.

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up continuing
Sex
All
Target Recruitment
200
Inclusion Criteria

Not provided

Exclusion Criteria

Patients with diabetic nephropathy more than 4 and during pregnancy and children were excluded from this study.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath